Infantile respiratory syncytial virus and human rhinovirus infections: Respective role in inception and persistence of wheezing

European Respiratory Journal

Volumn 45, Issue 3, 2015, Pages 774-789

  Rossi, Giovanni A ^a   Colin, Andrew A ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTHMA; DISEASE EXACERBATION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HUMAN RHINOVIRUS; IMMUNE RESPONSE; NEUROGENIC INFLAMMATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINOVIRUS INFECTION; SENSITIZATION; VIRUS PATHOGENESIS; WHEEZING; ABNORMAL RESPIRATORY SOUND; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INFANT; PATHOGENICITY; PATHOPHYSIOLOGY; PICORNAVIRUS INFECTION; RHINOVIRUS;

HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; PICORNAVIRIDAE INFECTIONS; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RHINOVIRUS;

EID: 84923950524     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00062714     Document Type: Article

References (142)

1. Global Initiativefor Asthma. Global Strategy for Asthma Management and Prevention. Revised 2014. www. ginasthma.org/local/uploads/files/GINA-Report-2014-Aug12.pdf Date last updated: December 2012. Date last accessed: October 3, 2013.
2. Duijts L. Fetal and infant origins of asthma. Eur J Epidemiol 2012; 27: 5-14.
3. Le Souëf PN. Gene-environmental interaction in the development of atopic asthma: new developments. Curr Opin Allergy Clin Immunol 2009; 9: 123-127.
4. von Mutius E. Environmental factors influencing the development and progression of pediatric asthma. J Allergy Clin Immunol 2002; 109 Suppl. 6: S525-S532.
5. Regamey N, Kaiser L, Roiha HL, et al. Viral etiology of acute respiratory infections with cough in infancy: a community-based birth cohort study. Pediatr Infect Dis J 2008; 27: 100-105.
6. Kusel MM, de Klerk NH, Holt PG, et al. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J 2006; 25: 680-686.
7. Kocevar VS, Bisgaard H, Jonsson L, et al. Variations in pediatric asthma hospitalization rates and costs between and within Nordic countries. Chest 2004; 125: 1680-1684.
8. Jackson DJ, Lemanske RF Jr. The role of respiratory virus infections in childhood asthma inception. Immunol Allergy Clin North Am 2010; 30: 513-522.
9. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541-545.
10. Henderson J, Hilliard TN, Sherriff A, et al. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005; 16: 386-392.
11. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178: 667-672.
12. Gern JE, Busse WW. Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol 2002; 2: 132-138.
13. Koponen P, Helminen M, Paassilta M, et al. Preschool asthma after bronchiolitis in infancy. Eur Respir J 2012; 39: 76-80.
14. Tortorolo L, Langer A, Polidori G, et al. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 2005; 172: 233-237.
15. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332: 133-138.
16. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161: 1501-1507.
17. Wennergren G, Kristjansson S. Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. Eur Respir J 2001; 18: 1044-1058.
18. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-1228.
19. Busse W, Gern J. Viruses in asthma. J Allergy Clin Immunol 1997; 100: 147-150.
20. Rakes GP, Arruda E, Ingram JM, et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. Am J Respir Crit Care Med 1999; 159: 785-790.
21. Heymann PW, Carper HT, Murphy DD, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004; 114: 239-247.
22. Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013; 368: 1791-1799.
23. Malhotra R, Ward M, Bright H, et al. Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect 2003; 5: 123-133.
24. Jansen RR, Wieringa J, Koekkoek SM, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol 2011; 49: 2631-2636.
25. Kumar S, Wang L, Fan J, et al. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol 2008; 46: 3063-3072.
26. Medici MC, Arcangeletti MC, Rossi GA, et al. Four year incidence of respiratory syncytial virus infection in infants and young children referred to emergency departments for lower respiratory tract diseases in Italy: the "Osservatorio VRS" Study (2000-2004). New Microbiol 2006; 29: 35-43.
27. Lanari M, Giovannini M, Giuffrè L, et al. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr Pulmonol 2002; 33: 458-465.
28. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360: 588-598.
29. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003; 143 Suppl. 5: S118-S126.
30. Rossi GA, Medici MC, Arcangeletti MC, et al. Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics. Eur J Pediatr 2007; 166: 1267-1272.
31. Murphy BR, Alling DW, Snyder MH, et al. Effect of age and pre-existing antibody on serum antibody response of infants and childrent to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol 1986; 24: 894-898.
32. Delgado MF, Coviello S, Monsalvo AC, et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 2009; 15: 34-41.
33. Yamazaki H, Tsutsumi H, Matsuda K, et al. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. J Gen Virol 1994; 75: 2115-2119.
34. Scagnolari C, Midulla F, Selvaggi C, et al. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med Microbiol Immunol 2012; 201: 311-317.
35. Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010; 23: 74-98.
36. Fonceca AM, Flanagan BF, Trinick R, et al. Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection. Thorax 2012; 67: 42-48.
37. Guo-Parke H, Canning P, Douglas I, et al. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med 2013; 188: 842-851.
38. McNamara PS, Flanagan BF, Selby AM, et al. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 2004; 23: 106-112.
39. Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 2005; 18: 541-555.
40. Lifland AW, Jung J, Alomas E, et al. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol 2012; 86: 8245-8258.
41. Shingai M, Azuma M, Ebihara T, et al. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-β induction. Int Immunol 2008; 20: 1169-1180.
42. Swedan S, Musiyenko A, Barik S. Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J Virol 2009; 83: 9682-9693.
43. Kauvar LM, Harcourt JL, Haynes LM, et al. Therapeutic targeting of respiratory syncytial virus G-protein. Immunotherapy 2010; 2: 655-661.
44. Bukreyev A, Yang L, Fricke J, et al. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J Virol 2008; 82: 12191-12204.
45. Legg JP, Hussain IR, Warner JA, et al. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168: 633-639.
46. Kristjansson S, Bjarnarson SP, Wennergren G, et al. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 2005; 116: 805-811.
47. Aberle JH, Aberle SW, Dworzak MN, et al. Reduced interferon-aγ expression in peripheral blood mononuclear cells of infants with severe respiratory-syncytial virus disease. Am J Respir Crit Care Med 1999; 160: 1263-1268.
48. Tang ML, Kemp AS, Thorburn J, et al. Reduced interferon-aγ secretion in neonates and subsequent atopy. Lancet 1994; 344: 983-985.
49. Gold DR, Bloomberg GR, Cruikshank WW, et al. Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses. J Allergy Clin Immunol 2009; 124: 1078-1087.
50. Copenhaver CC, Gern JE, Li Z, et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 2004; 170: 175-180.
51. McNamara PS, Flanagan BF, Hart CA, et al. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2005; 191: 1225-1232.
52. Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy - a review. Virus Genes 2006; 33: 235-252.
53. Shirey KA, Pletneva LM, Puche AC, et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent. Mucosal Immunol 2010; 3: 291-300.
54. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000; 117: 1162-1172.
55. Hornsleth A, Loland L, Larsen LB. Cytokines and chemokines in respiratory secretion and severity of disease in infants with respiratory syncytial virus (RSV) infection. J Clin Virol 2001; 21: 163-170.
56. Bont L, Heijnen CJ, Kavelaars A, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med 2000; 161: 1518-1523.
57. Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010; 65: 1045-1052.
58. Bont L, Ramilo O. The relationship between RSV bronchiolitis and recurrent wheeze: the chicken and the egg. Early Hum Dev 2011; 87 Suppl. 1: S51-S54.
59. Weinmayr G, Genuneit J, Nagel G, et al. International variations in associations of allergic markers and diseases in children: ISAAC Phase Two. Allergy 2010; 65: 766-775.
60. Simões EA, Carbonell-Estrany X, Rieger CH, et al. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010; 126: 256-262.
61. Piedimonte G. Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med 2001; 163: S18-S21.
62. Hu C, Wedde-Beer K, Auais A, et al. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol 2002; 283: L494-L502.
63. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-1162.
64. Bonini S, Lambiase A, Angelucci F, et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996; 93: 10955-10960.
65. Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol 2011; 46: 324-347.
66. Nilsson G, Forsberg-Nilsson K, Xiang Z, et al. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997; 27: 2295-2301.
67. Ehrhard PB, Erb P, Graumann U, et al. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci USA 1993; 90: 10984-10988.
68. Gern JE. The ABCs of rhinoviruses, wheezing, and asthma. J Virol 2010; 84: 7418-7426.
69. Vlasak M, Blomqvist S, Hovi T, et al. Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination. J Virol 2003; 77: 6923-6930.
70. McErlean P, Shackelton LA, Andrews E, et al. Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C). PloS one 2008; 3: e1847.
71. Crotty S, Andino R. Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin. Microbes Infect 2002; 4: 1301-1307.
72. Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155: 1159-1161.
73. Malmström K, Pitkaranta A, Carpen O, et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol 2006; 118: 591-596.
74. Peltola V, Waris M, Osterback R, et al. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis 2008; 197: 382-389.
75. Gern JE, Brooks GD, Meyer P, et al. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J Allergy Clin Immunol 2006; 117: 72-78.
76. Miller EK, Bugna J, Libster R, et al. Human rhinoviruses in severe respiratory disease in very low birth weight infants. Pediatrics 2012; 129: e60-e67.
77. van der Zalm MM, Wilbrink B, van Ewijk BE, et al. Highly frequent infections with human rhinovirus in healthy young children: a longitudinal cohort study. J Clin Virol 2011; 52: 317-320.
78. Rollinger JM, Schmidtke M. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery. Med Res Rev 2011; 31: 42-92.
79. Lee WM, Lemanske FR Jr, Evans MD, et al. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 2012; 186: 886-891.
80. Kieninger E, Fuchs O, Latzin P, et al. Rhinovirus infections in infancy and early childhood. Eur Respir J 2013; 41: 443-452.
81. Lemanske RF Jr, Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005; 116: 571-575.
82. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993; 307: 982-986.
83. Van Benten I, Koopman L, Niesters B, et al. Predominance of rhinovirus in the nose of symptomatic and asymptomatic infants. Pediatr Allergy Immunol 2003; 14: 363-370.
84. Van Gageldonk-Lafeber AB, Heijnen ML, Bartelds AI, et al. A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin Infect Dis 2005; 41: 490-497.
85. Fraenkel DJ, Bardin PG, Sanderson G, et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995; 151: 879-886.
86. Gern JE, French DA, Grindle KA, et al. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am J Respir Cell Mol Biol 2003; 28: 731-737.
87. Winther B, Gwaltney JM Jr, Hendley JO. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis 1990; 141: 839-845.
88. Bossios A, Psarras S, Gourgiotis D, et al. Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir Res 2005; 6: 114-125.
89. Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181: 1875-1884.
90. Winther B, Gwaltney JM Jr, Mygind N, et al. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 1986; 256: 1763-1767.
91. Sanders SP, Siekierski ES, Porter JD, et al. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 1998; 72: 934-942.
92. Message SD, Johnston SL. Host defense function of the airway epithelium in health and disease: clinical background. J Leukoc Biol 2004; 75: 5-17.
93. Slater L, Bartlett NW, Haas JJ, et al. Co-ordinated role of TLR-3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010; 6: e1001178.
94. Turner RB, Weingand KW, Yeh CH, et al. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 1998; 26: 840-846.
95. Skevaki CL, Psarras S, Volonaki E, et al. Rhinovirus-induced basic fibroblast growth factor release mediates airway remodeling features. Clin Transl Allergy 2012; 2: 14.
96. Lachowicz-Scroggins ME, Boushey HA, Finkbeiner WE, et al. Interleukin-13 induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. Am J Respir Cell Mol Biol 2010; 43: 652-661.
97. Wiehler S, Proud D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Cell Mol Physiol 2007; 293: L505-L515.
98. Hayden FG. Rhinovirus and the lower respiratory tract. Rev Med Virol 2004; 14: 17-31.
99. Montalbano MM, Lemanske RF Jr. Infections and asthma in children. Curr Opin Pediatr 2002; 14: 334-347.
100. Aya Takeyama A, Hashimoto K, Sato M, et al. Clinical and epidemiologic factors related to subsequent wheezing after virus-induced lower respiratory tract infections in hospitalized pediatric patients younger than 3 years. Eur J Pediatr 2014; 173: 959-966.
101. Miller EK, Lu X, Erdman DD, et al. Rhinovirus-associated hospitalizations in young children. J Infect Dis 2007; 195: 773-781.
102. Jartti T, Korppi M. Rhinovirus-induced bronchiolitis and asthma development. Pediatr Allergy Immunol 2011; 22: 350-355.
103. Kotaniemi-Syrjänen A, Vainionpää R, Reijonen TM, et al. Rhinovirus-induced wheezing in infancy the first sign of childhood asthma?. J Allergy Clin Immunol 2003; 111: 66-71.
104. Korppi M, Kotaniemi-Syrjänen A, Waris M, et al. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J 2004; 23: 995-999.
105. Gavala ML, Bertics PJ, Gern JE. Rhinoviruses, allergic inflammation, and asthma. Immunol Rev 2011; 242: 69-90.
106. van der Gugten AC, van der Zalm MM, Uiterwaal CS, et al. Human rhinovirus and wheezing: short and long-term associations in children. Pediatr Infect Dis J 2013; 32: 827-833.
107. Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119: 1105-1110.
108. Jackson DJ, Evans MD, Gangnon RE, et al. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med 2012; 185: 281-285.
109. Hales BJ, Martin AC, Pearce LJ, et al. Anti-bacterial IgE in the antibody responses of house dust mite allergic children convalescent from asthma exacerbation. Clin Exp Allergy 2009; 39: 1170-1178.
110. Xatzipsalti M, Psarros F, Konstantinou G, et al. Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment. Clin Exp Allergy 2008; 38: 466-472.
111. Papadopoulos NG, Stanciu LA, Papi A, et al. A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002; 57: 328-332.
112. Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol 2012; 130: 489-495.
113. Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201: 937-947.
114. Contoli M, Message SD, Laza-Stanca V, et al. Role of deficient type III interferon-eλ production in asthma exacerbations. Nat Med 2006; 12: 1023-1026.
115. Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma?. J Allergy Clin Immunol 2010; 125: 1202-1205.
116. Bianco A, Sethi SK, Allen JT, et al. Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1. Eur Respir J 1998; 12: 619-626.
117. Sethi SK, Bianco A, Allen JT, et al. Interferon-aγ downregulates the rhinovirus induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells. Clin Exp Immunol 1997; 110: 362-369.
118. Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-eκB-mediated transcription. J Biol Chem 1999; 274: 9707-9720.
119. Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007; 448: 470-473.
120. Bouzigon E, Corda E, Aschard H, et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med 2008; 359: 1985-1994.
121. Smit LA, Bouzigon E, Pin I, et al. 17q21 Variants modify the association between early respiratory infections and asthma. Eur Respir J 2010; 36: 57-64.
122. Halapi E, Gudbjartsson DF, Jonsdottir GM, et al. A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur J Hum Genet 2010; 18: 902-908.
123. Cali?kan M, Bochkov YA, Kreiner-Møller E, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013; 368: 1398-1407.
124. Halperin SA, Eggleston PA, Hendley JO, et al. Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am Rev Respir Dis 1983; 128: 806-810.
125. Bardin PG, Johnston SL, Pattemore PK. Viruses as precipitants of asthma symptoms II. Physiology and mechanisms. Clin Exp Allergy 1992; 22: 809-822.
126. Halperin SA, Eggleston PA, Beasley P, et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985; 132: 976-980.
127. Lemanske RF, Dick EC, Swenson CA, et al. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989; 83: 1-10.
128. Fleming HE, Little FF, Schnurr D, et al. Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med 1999; 160: 100-108.
129. Cheung D, Dick EC, Timmers MC, et al. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 1995; 152: 1490-1496.
130. Bardin PG, Sanderson G, Robinson BS, et al. Experimental rhinovirus infection in volunteers. Eur Respir J 1996; 9: 2250-2255.
131. Gern JE, Calhoun W, Swenson C, et al. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 1997; 155: 1872-1876.
132. Xepapadaki P, Papadopoulos NG, Bossios A, et al. Duration of postviral airway hyperresponsiveness in children with asthma: effect of atopy. J Allergy Clin Immunol 2005; 116: 299-304.
133. Sajjan U, Wang Q, Zhao Y, et al. Rhinovirus disrupts the barrier function of polarized airway epithelial cells. Am J Respir Crit Care Med 2008; 178: 1271-1281.
134. Petecchia L, Sabatini F, Usai C, et al. Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway. Lab Invest 2012; 92: 1140-1148.
135. Papadopoulos NG, Papi A, Psarras S, et al. Mechanisms of rhinovirus-induced asthma. Paediatr Respir Rev 2004; 5: 255-260.
136. Hosoda M, Yamaya M, Suzuki T, et al. Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils. J Immunol 2002; 169: 1482-1491.
137. Volovitz B, Faden H, Ogra PI. Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr 1988; 112: 218-222.
138. Grünberg K, Sterk PJ. Rhinovirus infections: induction and modulation of airways inflammation in asthma. Clin Exp Allergy 1999; 29 Suppl. 2: 65-73.
139. Friedlander S, Busse W. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005; 116: 267-273.
140. Wark PA, Johnston SL, Moric I, et al. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002; 19: 68-75.
141. Wark PA, Bucchieri F, Johnston SL, et al. IFN-aγ-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol 2007; 120: 586-593.
142. Message SD, Laza-Stanca V, Mallia P, et al. Rhinovirus induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci USA 2008; 105: 13562-13567.